Literature DB >> 13711997

The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans.

W A den HARTOG JAGER, J BETHLEM.   

Abstract

Entities:  

Keywords:  AUTONOMIC NERVOUS SYSTEM/pathology; CENTRAL NERVOUS SYSTEM/pathology; PARALYSIS AGITANS/pathology

Mesh：

Year:  1960        PMID： 13711997      PMCID： PMC497426          DOI： 10.1136/jnnp.23.4.283

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Cytoplasmic inclusions in ganglion cells associated with parkinsonian states: a neurocellular change studied in 53 cases and 206 controls.

Authors:  L E LIPKIN
Journal:  Am J Pathol       Date:  1959 Nov-Dec       Impact factor: 4.307

2.  The brain-stem lesions in Parkinsonism.

Authors:  J G GREENFIELD; F D BOSANQUET
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-11       Impact factor: 10.154

3.  [Cell changes in the nucleus coeruleus in Parkinson syndrome].

Authors:  D BEHEIM-SCHWARZBACH
Journal:  J Nerv Ment Dis       Date:  1952-12       Impact factor: 2.254

4.  Tabes of Friedreich with degeneration of the substantia nigra, a special type of hereditary parkinsonism.

Authors:  A BIEMOND; J L SINNEGE
Journal:  Confin Neurol       Date:  1955
  4 in total
  67 in total

1.  Neuropathology in mice expressing human alpha-synuclein.

Authors:  H van der Putten; K H Wiederhold; A Probst; S Barbieri; C Mistl; S Danner; S Kauffmann; K Hofele; W P Spooren; M A Ruegg; S Lin; P Caroni; B Sommer; M Tolnay; G Bilbe
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Comparison of heart rate variability analysis methods in patients with Parkinson's disease.

Authors:  M Kallio; K Suominen; A M Bianchi; T Mäkikallio; T Haapaniemi; S Astafiev; K A Sotaniemi; V V Myllyä; U Tolonen
Journal:  Med Biol Eng Comput       Date:  2002-07       Impact factor: 2.602

3.  ARTERIOSCLEROSIS IN PARKINSONISM.

Authors:  M J EADIE; J M SUTHERLAND
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-06       Impact factor: 10.154

4.  Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease.

Authors:  K Oyanagi; K Wakabayashi; E Ohama; S Takeda; Y Horikawa; T Morita; F Ikuta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 5.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

6.  Lafora-like inclusion bodies in the CNS of aged dogs.

Authors:  Y Suzuki; K Akiyama; S Suu
Journal:  Acta Neuropathol       Date:  1978-12-15       Impact factor: 17.088

7.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

8.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

9.  A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.

Authors:  M Yoshita; J Taki; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

10.  Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.

Authors:  Thomas Gerald Beach; Charles H Adler; Lucia I Sue; Jeffrey B Peirce; Jyothi Bachalakuri; Jessica E Dalsing-Hernandez; Lih Fen Lue; John N Caviness; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.